Clinical Trial Update: Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla [Phase 2]

View source ↗

Summary

Phase II clinical trial update for an immunotherapy in carcinomas arising from the renal medulla. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Medullary Carcinoma

Drugs mentioned

• Immunotherapy (unspecified)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Carcinomas, Renal Medullary Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING